Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2009 1
2010 4
2011 2
2012 2
2013 2
2014 1
2015 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Correlates of the molecular vaginal microbiota composition of African women.
Gautam R, Borgdorff H, Jespers V, Francis SC, Verhelst R, Mwaura M, Delany-Moretlwe S, Ndayisaba G, Kyongo JK, Hardy L, Menten J, Crucitti T, Tsivtsivadze E, Schuren F, van de Wijgert JH; Vaginal Biomarkers Study Group. Gautam R, et al. BMC Infect Dis. 2015 Feb 21;15:86. doi: 10.1186/s12879-015-0831-1. BMC Infect Dis. 2015. PMID: 25887567 Free PMC article.
Prevalence and correlates of bacterial vaginosis in different sub-populations of women in sub-Saharan Africa: a cross-sectional study.
Jespers V, Crucitti T, Menten J, Verhelst R, Mwaura M, Mandaliya K, Ndayisaba GF, Delany-Moretlwe S, Verstraelen H, Hardy L, Buvé A, van de Wijgert J; Vaginal Biomarkers Study Group. Jespers V, et al. PLoS One. 2014 Oct 7;9(10):e109670. doi: 10.1371/journal.pone.0109670. eCollection 2014. PLoS One. 2014. PMID: 25289640 Free PMC article.
Comparison of the Generic HIV Viral Load assay with the Amplicor HIV-1 monitor v1.5 and Nuclisens HIV-1 EasyQ v1.2 techniques for plasma HIV-1 RNA quantitation of non-B subtypes: the Kesho Bora preparatory study.
Rouet F, Foulongne V, Viljoen J, Steegen K, Becquart P, Valéa D, Danaviah S, Segondy M, Verhofstede C, Van de Perre P; WHO/ANRS 1289 Kesho Bora Study Group. Rouet F, et al. J Virol Methods. 2010 Feb;163(2):253-7. doi: 10.1016/j.jviromet.2009.10.005. Epub 2009 Oct 27. J Virol Methods. 2010. PMID: 19837114
Maternal HIV-1 disease progression 18-24 months postdelivery according to antiretroviral prophylaxis regimen (triple-antiretroviral prophylaxis during pregnancy and breastfeeding vs zidovudine/single-dose nevirapine prophylaxis): The Kesho Bora randomized controlled trial.
Kesho Bora Study Group. Kesho Bora Study Group. Clin Infect Dis. 2012 Aug;55(3):449-60. doi: 10.1093/cid/cis461. Epub 2012 May 9. Clin Infect Dis. 2012. PMID: 22573845 Free PMC article. Clinical Trial.
13 results